{"text": ["Health", "Canada", "Approves", "the", "Use", "of", "RINVOQ\u00ae", "(upadacitinib)", "for", "the", "Treatment", "of", "Adults", "and", "Adolescents", "with", "Moderate", "to", "Severe", "Atopic", "Dermatitis"], "created_at": "2021-10-07 17:22:00"}
{"text": ["AbbVie", "Touts", "Additional", "Rinvoq", "Data", "In", "Inflammatory", "Spinal", "Arthritis"], "created_at": "2021-10-07 16:49:39"}
{"text": ["Why", "AbbVie", "Stock", "Sank", "in", "September"], "created_at": "2021-10-07 14:30:00"}
{"text": ["10", "Dividend", "Stocks", "to", "Increase", "Your", "Monthly", "Income"], "created_at": "2021-10-07 14:24:22"}
{"text": ["AbbVie", "Higher", "on", "Rinvoq", "Trial", "Progress", "to", "Treat", "Spinal", "Arthritis"], "created_at": "2021-10-07 12:38:00"}
{"text": ["AbbVie's", "Upadacitinib", "(RINVOQ\u00ae)", "Met", "Primary", "and", "Most", "Ranked", "Secondary", "Endpoints", "in", "Phase", "3", "Study", "for", "Non-Radiographic", "Axial", "Spondyloarthritis"], "created_at": "2021-10-07 12:16:00"}
{"text": ["AbbVie's", "RINVOQ\u00ae", "(upadacitinib)", "Met", "Primary", "and", "All", "Ranked", "Secondary", "Endpoints", "in", "Phase", "3", "Study", "in", "Ankylosing", "Spondylitis"], "created_at": "2021-10-07 12:15:00"}
